Published in

Taylor and Francis Group, Leukemia & Lymphoma, 3(61), p. 680-690, 2019

DOI: 10.1080/10428194.2019.1675881

Links

Tools

Export citation

Search in Google Scholar

The effects of different schedules of bortezomib, melphalan, and prednisone for patients with newly diagnosed multiple myeloma who are transplant ineligible: a matching-adjusted indirect comparison

Journal article published in 2019 by Maria-Victoria Mateos ORCID, Jesus San-Miguel ORCID, Hartmut Goldschmidt ORCID, Pieter Sonneveld ORCID, Meletios A. Dimopoulos ORCID, Bart Heeg ORCID, Mahmoud Hashim ORCID, William Deraedt ORCID, Peter Hu ORCID, Annette Lam ORCID, Jianming He ORCID
This paper was not found in any repository, but could be made available legally by the author.
This paper was not found in any repository, but could be made available legally by the author.

Full text: Unavailable

Red circle
Preprint: archiving forbidden
Orange circle
Postprint: archiving restricted
Upload
Red circle
Published version: archiving forbidden
Policy details
Data provided by SHERPA/RoMEO